Fidson Healthcare Plc has once again demonstrated its strong presence in the pharmaceutical sector, with the announcement of a dividend of 55 kobo per share for the year ending December 31, 2022. This decision, approved unanimously by shareholders during the 24th Annual General Meeting held in Lagos, represents a 10 percent increase from the 50 kobo per share dividend paid in the previous year.
Fidson Healthcare is on a path of expansion to meet the growing demand for critical therapeutic area drugs not only in Nigeria but also in other West African countries. The company’s commitment to increasing pharmaceutical production capacity underscores its dedication to providing essential healthcare solutions.
In financial terms, Fidson reported an impressive turnover of N40.634 billion for the fiscal year ending December 31, 2022. This signifies a remarkable 31.7 percent increase compared to the N30.861 billion in revenue recorded in 2021.
Dr. Fidelis Ayebae, the Founder and Managing Director of Fidson Healthcare Plc, attributed the company’s exceptional performance to the unwavering support, trust, and loyalty of its stakeholders and valued customers. He emphasized the pivotal role that customers’ trust and continued patronage play in the company’s success, especially as an indigenous pharmaceutical company operating in a highly competitive market.
Dr. Ayebae stated, “Our business’s success story has been built upon the foundation of trust from our customers and their consistent preference for our brands. This trust and loyalty have been the driving force behind our unwavering commitment to excellence across all aspects of our operations. Consequently, it has yielded substantial returns, fueled our business expansion, and solidified our position as an industry leader.”
He continued, “Despite the challenging business environment, we remain steadfast in fortifying our internal control mechanisms and investing in the development of future leaders. This commitment ensures the sustained profitability of the company while simultaneously enhancing the quality of life for our stakeholders.”
As Fidson Healthcare continues to expand rapidly, seek strategic partnerships, and empower its workforce, the company anticipates achieving the desired stability that will propel it into the next phase of growth, relevance, and market dominance.
One notable aspect of the Annual General Meeting was the unanimous re-election of Dr. Vincent Ahonkhai, Mrs. Aishatu P. Sadauki, and Mr. Emmanuel E. Imoagene as non-executive directors. The Board Chairman, Mr. Segun Adebanji (FCA), praised the three highly professional and accomplished board members for their valuable contributions to the company’s strategic objectives.
Shareholders expressed their satisfaction with Fidson Healthcare’s consistent performance, with Chief Timothy Adesiyan commending the company’s unwavering commitment to dividend payments despite the challenging business environment. Barrister Adetutu Siyonbola also lauded the management’s transparency and punctuality in conducting annual general meetings, which further bolstered shareholder confidence in the company.
